Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Revenue by Segment

Period Ending	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Collaboration	9.78M	8.75M	9.30M	8.37M	6.85M	12.34M	-1.49M	46.11M								-	-	-	-	-	-	-	-	-
Collaboration Growth	42.75%	-29.14%	-	-81.86%	-88.35%	-96.60%	-	-96.94%								-	-	-	-	-	-	-	-	-
Contract	-	5.65M	5.01M	55.34M	55.18M	54.08M	54.25M	2.15M	1.65M
Contract Growth	-	-89.56%	-90.77%	2,478.84%	3,252.19%	30.75%	3.22%	-95.93%	-96.88%
Grant	2.82M	4.61M	6.56M	10.52M	16.63M	21.27M	35.66M	46.66M
Grant Growth	-83.03%	-78.34%	-81.60%	-77.45%	-75.21%	-66.46%	-27.17%	32.25%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.